Deepak Shripad Phadke Net Worth

The estimated Net Worth of Deepak Shripad Phadke is at least 23.2 千$ dollars as of 12 December 2006. Deepak Phadke owns over 4,720 units of Vanda Pharmaceuticals Inc stock worth over 23,222$ and over the last 18 years Deepak sold VNDA stock worth over 0$.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Deepak Phadke VNDA stock SEC Form 4 insiders trading

Deepak has made over 1 trades of the Vanda Pharmaceuticals Inc stock since 2006, according to the Form 4 filled with the SEC. Most recently Deepak exercised 4,720 units of VNDA stock worth 1,558$ on 12 December 2006.

The largest trade Deepak's ever made was exercising 4,720 units of Vanda Pharmaceuticals Inc stock on 12 December 2006 worth over 1,558$. On average, Deepak trades about 4,720 units every 0 days since 2006. As of 12 December 2006 Deepak still owns at least 4,720 units of Vanda Pharmaceuticals Inc stock.

You can see the complete history of Deepak Phadke stock trades at the bottom of the page.

What's Deepak Phadke's mailing address?

Deepak's mailing address filed with the SEC is 9605 MEDICAL CENTER DRIVE, SUITE 300, ROCKVILLE, MD, 20850.

Insiders trading at Vanda Pharmaceuticals Inc

Over the last 19 years, insiders at Vanda Pharmaceuticals Inc have traded over 267,060,716$ worth of Vanda Pharmaceuticals Inc stock and bought 5,567,934 units worth 25,606,507$ . The most active insiders traders include Kevin Ctang Capital Managem...、Nicole Vitullo、Jesse I Treu. On average, Vanda Pharmaceuticals Inc executives and independent directors trade stock every 31 days with the average trade being worth of 546,607$. The most recent stock trade was executed by Kevin Patrick Moran on 29 July 2024, trading 2,251 units of VNDA stock currently worth 13,326$.

What does Vanda Pharmaceuticals Inc do?

vanda is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients.

Complete history of Deepak Phadke stock trades at Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals Inc executives and stock owners

Vanda Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Mihael Polymeropoulos,
  President, Chief Executive Officer, Director
• Timothy Williams,
  Senior Vice President, General Counsel, Secretary
• Gunther Birznieks,
  Senior Vice President - Business Development
• Dr. Mihael H. Polymeropoulos M.D.,
  Founder, Pres, CEO & Chairman of The Board
• Dr. Mihael H. Polymeropoulos,
  Founder, Pres, CEO & Director
• Joakim Wijkstrom,
  Sr. VP & Chief Marketing Officer
• Kevin Patrick Moran,
  Sr. VP, CFO & Treasurer
• Timothy Williams,
  Sr. VP, Gen. Counsel & Sec.
• Phaedra Chrousos,
  Independent Director
• Anne Ward,
  Independent Director
• H. Thomas Watkins,
  Independent Chairman of the Board
• Richard Dugan,
  Independent Director
• Stephen Mitchell,
  Independent Director
• Aranthan Jones,
  Chief Corporate Affairs and Communications Officer
• Joakim Wijkstrom,
  Senior Vice President, Chief Marketing Officer
• Kevin Moran,
  Acting Chief Financial Officer, Vice President, Treasurer
• Elizabeth Van Every,
  Head of Corp. Affairs
• Scott L. Howell,
  Chief People Officer
• Kenneth Bate,
  Director
• Michael F Cola,
  Director
• James E Deerfield Mgmt L.P....,
  
• Paolo Baroldi,
  Chief Medical Officer
• Vincent Milano,
  Director
• Steven A Shallcross,
  Sr. VP, CFO, Treasurer
• Albert W. Gianchetti,
  Sr.VP,Chief Commercial Officer
• Tage Honore,
  
• Richard L. Gulino,
  SVP & General Counsel
• James Patrick Kelly,
  EVP & Chief Financial Officer
• Gian Piero Reverberi,
  SVP & Chief Commercial Officer
• James B Tananbaum,
  Director
• Capital Ii Llccare Capital ...,
  
• Robert J More,
  10% owner
• Nicole Vitullo,
  10% owner
• Management Co Ii Llcprospec...,
  
• Brian H Dovey,
  10% owner
• Deepak Shripad Phadke,
  Vice President Manufacturing
• Ventures Iv Lprho Ventures ...,
  
• James C Blair,
  10% owner
• Inc /De Medimmune,
  10% owner
• Wayne T Hockmeyer,
  Director
• Ventures Iv Lprho Managemen...,
  
• Vi Associates, L.P. Dp,
  10% owner
• Partners Vi, L.P. Domain,
  10% owner
• Venture Partners Ii Lpprosp...,
  
• Jesse I Treu,
  10% owner
• Sciences Investment Fund Pt...,
  
• Kathleen K Schoemaker,
  10% owner
• Thomas Edward Gibbs,
  SVP, Chief Commercial Officer
• James E Deerfield Mgmt L.P....,
  
• Howard H Pien,
  Director
• Steven K Galson,
  Director
• Robert Repella,
  SVP & Chief Commercial Officer
• Stephanie Rast Irish,
  Sr. VP, Acting CFO/Treasurer
• John Joseph Feeney,
  Acting Chief Medical Officer
• Argeris N Karabelas,
  Chairman of the Board
• Brian K Halak,
  Director
• William D Clark,
  Sr VP, Chief Business Officer
• David Russ Ramsay,
  Director
• Kevin Ctang Capital Managem...,